Skip to main content

Sidebar

Main Menu

Home
Highlights
Research
Press Releases
News Reports
Press Room
Staff Awards

Quicklinks

NUS Home
Email
Library
Student
Staff
Alumni

NUS Home
Email
Library
Student
Staff
Alumni

Home
Highlights
Research
Press Releases
News Reports
Press Room
Staff Awards

twitter share quote

21

August

2021

|

13:17

Asia/Singapore

Vaccine by Arcturus and Duke-NUS in phase 2 trials

The Straits Times, 21 August 2021, Asian Insider, pA25
The Straits Times, 21 August 2021, Asian Insider, pA24

Newsroom

Share this page

Vaccine by Arcturus and Duke-NUS in phase 2 trials

Share on: Twitter

Share on: Facebook

Share on: LinkedIn

Follow us on

Visit our Facebook page (opens in new window)
Follow us on X (opens in new window)
(opens in new window)
Visit our LinkedIn page (opens in new window)
Visit our Youtube profile (opens in new window)
(opens in new window)
(opens in new window)

Latest news

24

Apr

2024

-

Future of AI on media landscape greeted with cautious optimism at CNM Leaders Summit

22

Apr

2024

-

Harnessing the power of soil microbes for the sustainable production of green chemicals

22

Apr

2024

-

A hotter Singapore will change how we work and live

22

Apr

2024

-

Can KMT become a bridge for cross-Strait reconciliation and China-US reconciliation?

19

Apr

2024

-

NUS, ISTARI and CSA drive cybersecurity innovation at inaugural ISTARI CHARTER APAC Congress 2024

19

Apr

2024

-

ASEAN’s strong diplomatic links key to boosting resilience amid global geopolitical risks

National University of Singapore

21 Lower Kent Ridge Road
Singapore 119077
+65 6516 6666

© National University of Singapore. All Rights Reserved.

Legal
Branding guidelines
Contact us
中文

Privacy Notice

This site uses cookies. By clicking accept or continuing to use this site, you agree to our use of cookies. For more details about cookies and how to manage them, please see our Privacy Notice.